Literature DB >> 27159176

Allogeneic-matched sibling stem cell transplantation in a 13-year-old boy with ataxia telangiectasia and EBV-positive non-Hodgkin lymphoma.

R Beier1, K-W Sykora1, W Woessmann2, B Maecker-Kolhoff1, M Sauer1, H H Kreipe3, T Dörk-Bousset4, C Kratz1, M Lauten5.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27159176     DOI： 10.1038/bmt.2016.93

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  17 in total

1.  Non-Hodgkin's lymphoma in pediatric patients with chromosomal breakage syndromes (AT and NBS): experience from the BFM trials.

Authors:  K Seidemann; G Henze; J D Beck; A Sauerbrey; J Kühl; G Mann; A Reiter
Journal:  Ann Oncol       Date:  2000       Impact factor: 32.976

2.  Long-term survival after allogeneic-matched sibling PBSC transplantation with conditioning consisting of low-dose busilvex and fludarabine in a 3-year-old boy with ataxia-telangiectasia syndrome and ALL.

Authors:  M Ussowicz; J Musiał; E Duszeńko; O Haus; K Kałwak
Journal:  Bone Marrow Transplant       Date:  2012-10-29       Impact factor: 5.483

3.  Morbidity and mortality from ataxia-telangiectasia are associated with ATM genotype.

Authors:  Romain Micol; Lilia Ben Slama; Felipe Suarez; Loïc Le Mignot; Julien Beauté; Nizar Mahlaoui; Catherine Dubois d'Enghien; Anthony Laugé; Janet Hall; Jérôme Couturier; Louis Vallée; Bruno Delobel; François Rivier; Karine Nguyen; Thierry Billette de Villemeur; Jean-Louis Stephan; Pierre Bordigoni; Yves Bertrand; Nathalie Aladjidi; Jean-Michel Pedespan; Caroline Thomas; Isabelle Pellier; Michel Koenig; Olivier Hermine; Capucine Picard; Despina Moshous; Bénédicte Neven; Fanny Lanternier; Stéphane Blanche; Marc Tardieu; Marianne Debré; Alain Fischer; Dominique Stoppa-Lyonnet
Journal:  J Allergy Clin Immunol       Date:  2011-06-12       Impact factor: 10.793

4.  Hepatic veno-occlusive disease in ataxia-telangiectasia.

Authors:  N Srisirirojanakorn; M J Finegold; G S Gopalakrishna; W J Klish
Journal:  J Pediatr       Date:  1999-06       Impact factor: 4.406

5.  Promising therapy results for lymphoid malignancies in children with chromosomal breakage syndromes (Ataxia teleangiectasia or Nijmegen-breakage syndrome): a retrospective survey.

Authors:  Klaus Bienemann; Birgit Burkhardt; Simon Modlich; Ulrike Meyer; Anja Möricke; Kirsten Bienemann; Christine Mauz-Körholz; Gabriele Escherich; Martin Zimmermann; Dieter Körholz; Gritta Janka-Schaub; Martin Schrappe; Alfred Reiter; Arndt Borkhardt
Journal:  Br J Haematol       Date:  2011-09-19       Impact factor: 6.998

6.  Outcomes of mismatched and unrelated donor hematopoietic stem cell transplantation in Fanconi anemia conditioned with chemotherapy only.

Authors:  M M Chao; J S Kuehl; G Strauss; H Hanenberg; D Schindler; H Neitzel; C Niemeyer; I Baumann; H von Bernuth; J Rascon; M Nagy; M Zimmermann; C P Kratz; W Ebell
Journal:  Ann Hematol       Date:  2015-04-12       Impact factor: 3.673

7.  The Saudi experience in fludarabine-based conditioning regimens in patients with Fanconi anemia undergoing stem cell transplantation: excellent outcome in recipients of matched related stem cells but not in recipients of unrelated cord blood stem cells.

Authors:  Mouhab Ayas; Amal Al-Seraihi; Hassan El-Solh; Ali Al-Ahmari; Ashraf Khairy; Abdelmoneim Aldali; Samer Markiz; Khawar Siddiqui; Abdullah Al-Jefri
Journal:  Biol Blood Marrow Transplant       Date:  2011-08-24       Impact factor: 5.742

8.  Incidence, presentation, and prognosis of malignancies in ataxia-telangiectasia: a report from the French national registry of primary immune deficiencies.

Authors:  Felipe Suarez; Nizar Mahlaoui; Danielle Canioni; Chantal Andriamanga; Catherine Dubois d'Enghien; Nicole Brousse; Jean-Philippe Jais; Alain Fischer; Olivier Hermine; Dominique Stoppa-Lyonnet
Journal:  J Clin Oncol       Date:  2014-12-08       Impact factor: 44.544

9.  Bladder wall telangiectasis causing life-threatening haematuria in ataxia-telangiectasia: a new observation.

Authors:  Jonathan M Cohen; Peter Cuckow; E Graham Davies
Journal:  Acta Paediatr       Date:  2008-05       Impact factor: 2.299

10.  Haemorrhagic cystitis and polyomavirus JC infection in ataxia telangiectasia.

Authors:  Martin Christmann; Sonja Heitkamp; Evelyn Lambrecht; Kristina Doerries; Ralf Schubert; Stefan Zielen
Journal:  J Pediatr Urol       Date:  2009-03-21       Impact factor: 1.830
View more
  7 in total

1.  Utility of DNA, RNA, Protein, and Functional Approaches to Solve Cryptic Immunodeficiencies.

Authors:  Margot A Cousin; Matthew J Smith; Ashley N Sigafoos; Jay J Jin; Marine I Murphree; Nicole J Boczek; Patrick R Blackburn; Gavin R Oliver; Ross A Aleff; Karl J Clark; Eric D Wieben; Avni Y Joshi; Pavel N Pichurin; Roshini S Abraham; Eric W Klee
Journal:  J Clin Immunol       Date:  2018-04-18       Impact factor: 8.317

Review 2.  Ataxia telangiectasia: a review.

Authors:  Cynthia Rothblum-Oviatt; Jennifer Wright; Maureen A Lefton-Greif; Sharon A McGrath-Morrow; Thomas O Crawford; Howard M Lederman
Journal:  Orphanet J Rare Dis       Date:  2016-11-25       Impact factor: 4.123

Review 3.  Pre-emptive Allogeneic Hematopoietic Stem Cell Transplantation in Ataxia Telangiectasia.

Authors:  Shahrzad Bakhtiar; Sandra Woelke; Sabine Huenecke; Matthias Kieslich; Alexander Malcolm Taylor; Ralf Schubert; Stefan Zielen; Peter Bader
Journal:  Front Immunol       Date:  2018-10-29       Impact factor: 7.561

4.  Reconstitution of the Ataxia-Telangiectasia Cellular Phenotype With Lentiviral Vectors.

Authors:  Diana Carranza; Sara Torres-Rusillo; Gloria Ceballos-Pérez; Eva Blanco-Jimenez; Martin Muñoz-López; José L García-Pérez; Ignacio J Molina
Journal:  Front Immunol       Date:  2018-11-20       Impact factor: 7.561

5.  The natural history of ataxia-telangiectasia (A-T): A systematic review.

Authors:  Emily Petley; Alexander Yule; Shaun Alexander; Shalini Ojha; William P Whitehouse
Journal:  PLoS One       Date:  2022-03-15       Impact factor: 3.752

6.  The paradigm of hematological malignant versus non-malignant manifestations, driven by primary immunodeficiencies: a complex interplay.

Authors:  C Kelaidi; V Tzotzola; S Polychronopoulou
Journal:  Fam Cancer       Date:  2021-06-15       Impact factor: 2.375

7.  A Systematic Review on Predisposition to Lymphoid (B and T cell) Neoplasias in Patients With Primary Immunodeficiencies and Immune Dysregulatory Disorders (Inborn Errors of Immunity).

Authors:  Irbaz Bin Riaz; Warda Faridi; Mrinal M Patnaik; Roshini S Abraham
Journal:  Front Immunol       Date:  2019-04-16       Impact factor: 7.561
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.